Biomotion Sciences Ordinary Stock Shares Owned By Insiders
| SLXN Stock | 2.14 0.76 26.21% |
Biomotion Sciences Ordinary fundamentals help investors to digest information that contributes to Biomotion Sciences' financial success or failures. It also enables traders to predict the movement of Biomotion Stock. The fundamental analysis module provides a way to measure Biomotion Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomotion Sciences stock.
Biomotion | Shares Owned By Insiders |
Biomotion Sciences Ordinary Company Shares Owned By Insiders Analysis
Biomotion Sciences' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Biomotion Sciences Shares Owned By Insiders | 93.75 % |
Most of Biomotion Sciences' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomotion Sciences Ordinary is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biomotion Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Biomotion Sciences is extremely important. It helps to project a fair market value of Biomotion Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Biomotion Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biomotion Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biomotion Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 93% of Biomotion Sciences Ordinary are shares owned by insiders. This is much higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Biomotion Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomotion Sciences' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomotion Sciences could also be used in its relative valuation, which is a method of valuing Biomotion Sciences by comparing valuation metrics of similar companies.Biomotion Sciences is currently under evaluation in shares owned by insiders category among its peers.
Biomotion Fundamentals
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.62 | ||||
| Current Valuation | 8.29 M | ||||
| Shares Outstanding | 9.77 M | ||||
| Shares Owned By Insiders | 93.75 % | ||||
| Shares Owned By Institutions | 13.13 % | ||||
| Number Of Shares Shorted | 60.49 K | ||||
| EBITDA | (1.35 M) | ||||
| Net Income | (4.94 M) | ||||
| Total Debt | 17.31 M | ||||
| Book Value Per Share | 4.67 X | ||||
| Cash Flow From Operations | (4.53 M) | ||||
| Earnings Per Share | (0.66) X | ||||
| Market Capitalization | 9.87 M | ||||
| Total Asset | 5.26 M | ||||
| Retained Earnings | (26.81 M) | ||||
| Working Capital | 2.78 M | ||||
| Net Asset | 5.26 M |
About Biomotion Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomotion Sciences Ordinary's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomotion Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomotion Sciences Ordinary based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biomotion Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomotion Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomotion Sciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Biomotion Stock
Moving against Biomotion Stock
| 0.75 | ERNA | Eterna Therapeutics | PairCorr |
| 0.73 | SLS | Sellas Life Sciences | PairCorr |
| 0.7 | VALN | Valneva SE ADR | PairCorr |
| 0.7 | GNFT | Genfit | PairCorr |
| 0.62 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Biomotion Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomotion Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomotion Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomotion Sciences Ordinary to buy it.
The correlation of Biomotion Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomotion Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomotion Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomotion Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biomotion Sciences Piotroski F Score and Biomotion Sciences Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomotion Sciences. If investors know Biomotion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomotion Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Return On Assets (0.62) | Return On Equity (1.17) |
The market value of Biomotion Sciences is measured differently than its book value, which is the value of Biomotion that is recorded on the company's balance sheet. Investors also form their own opinion of Biomotion Sciences' value that differs from its market value or its book value, called intrinsic value, which is Biomotion Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomotion Sciences' market value can be influenced by many factors that don't directly affect Biomotion Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomotion Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomotion Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomotion Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.